Author

Yubo Wang

Observed name: Wang, Yubo

Institutions: Harbin Normal University, Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Tian Tan Hospital

Observed institutions: Scripps Research Institute, Harbin Normal University, Guangxi University, Jiamusi University, Capital Medical University, Xiamen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Purdue University West Lafayette, Beijing Tian Tan Hospital, Zhongshan Hospital of Xiamen University

ORCID: 0000-0001-8248-8959

Observed ORCID: 0000-0001-8248-8959

OpenAlex ID: A5108952725

diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease

2025 · Piu Banerjee, Yubo Wang, et al. · Antioxidants · 15

Targeted pH-responsive biomimetic nanoparticle-mediated starvation-enhanced chemodynamic therapy combined with chemotherapy for ovarian cancer treatment

2024 · Mingzhu Ye, Roumei Ye, et al. · International Journal of Pharmaceutics · 10

Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease

2025 · Chang-ki Oh, Yubo Wang, et al. · Neurotherapeutics · 6

C-TLSAN: Content-Enhanced Time-Aware Long- and Short-Term Attention Network for Personalized Recommendation

2025 · Liang, Siqi, Zhang, Yudi, et al. · arXiv (Cornell University) · 4

Microneedle-mediated drug delivery systems for brain diseases

2026 · Jia Li, Yubo Wang, et al. · Nanomedicine Nanotechnology Biology and Medicine · 1

Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack

2026 · Jinxi Lin, Hongyu Zhou, et al. · Stroke

Works count: 6

Citation count: 36

H-index: 4

I10-index: 2